# Commission Implementing Regulation (EU) No 1091/2014Show full title

Commission Implementing Regulation (EU) No 1091/2014 of 16 October 2014 approving tralopyril as a new active substance for            use in biocidal products for product-type 21 (Text with EEA relevance)         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 1091/2014                     

# of 16 October 2014

# approving tralopyril as a new active substance for use in biocidal products for product-type 21

# (Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making                           available on the market and use of biocidal products(1), and in particular Article 90(2) thereof,                        

Whereas:

(1)The United Kingdom has received on 17 July 2007 an application, in accordance with Article 11(1) of Directive 98/8/EC of the                              European Parliament and of the Council(2), for the inclusion of the active substance tralopyril in its Annex I for use in product-type 21, antifouling products, as                              defined in Annex V to that Directive.

(2)Tralopyril was not on the market on 14 May 2000 as an active substance of a biocidal product.

(3)The United Kingdom submitted the assessment report, together with its recommendations, to the Commission on 1 September 2009                              in accordance with Article 11(2) of Directive 98/8/EC.

(4)The opinion of the European Chemicals Agency was formulated on 8 April 2014 by the Biocidal Product Committee, having regard                              to the conclusions of the evaluating competent authority.

(5)It appears from that opinion that biocidal products used for product-type 21 and containing tralopyril may be expected to                              satisfy the requirements laid down in Article 5 of Directive 98/8/EC provided that certain specifications and conditions relating                              to its use are satisfied.

(6)It is therefore appropriate to approve tralopyril for use in biocidal products for product-type 21 subject to compliance with                              certain specifications and conditions.

(7)Since the evaluations did not address nanomaterials, the approvals should not cover such materials pursuant to Article 4(4)                              of Regulation (EU) No 528/2012.

(8)A reasonable period should be allowed to elapse before an active substance is approved, in order to permit interested parties                              to take the preparatory measures necessary to meet the new requirements laid down.

(9)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

Tralopyril shall be approved as an active substance for use in biocidal products for product-type 21, subject to the specifications                     and conditions set out in the Annex.                  

# Article 2U.K.

This Regulation shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 16 October 2014.

*For the Commission*                            

*The President*                            

José Manuel Barroso                            

## ANNEXU.K.

1

OJ L 167, 27.6.2012, p. 1.                           

2

Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products                              on the market (OJ L 123, 24.4.1998, p. 1).